Therapeutic use of chardonnay seed products

Patent metadata

Field	Value
Publication number	US-10105409-B2
Application number	US-201314398093-A
Country	US
Kind code	B2
Filing date	Apr 29, 2013
Priority date	Apr 30, 2012
Publication date	Oct 23, 2018
Grant date	Oct 23, 2018

Abstract

The present disclosure relates to health benefits of Chardonnay seed products.

First claim

What is claimed is:

1. A method of treating metabolic syndrome in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of cold press or hot press dried chardonnay seed flour.

2. The method of claim 1 , wherein the treating metabolic syndrome reduces cholesterol of the mammal.

3. The method of claim 1 , wherein the treating metabolic syndrome reduces the weight of the mammal.

4. The method of claim 1 , wherein the treating metabolic syndrome reduces the weight of the liver of the mammal.

5. The method of claim 1 , wherein the treating metabolic syndrome restores blood glucose levels to normal in the mammal.

6. The method of claim 1 , wherein the effective amount is at least 1.0 g per day is administered to the mammal.

7. The method of claim 1 , wherein the effective amount is at least 0.2 g/kg of body weight is administered to the mammal.

8. The method of claim 1 , wherein the mammal is a human.

9. A method of reducing the weight of a liver in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of cold or hot press dried Chardonnay seed flour.

10. The method of claim 9 , wherein the effective amount is at least 0.2 g/kg of body weight is administered to the mammal.

11. The method of claim 9 , wherein the effective amount is at least 1.0 g per day is administered to the mammal.

12. The method of claim 9 , wherein the mammal is a human.

13. A method of reducing cholesterol in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of cold or hot press dried Chardonnay seed flour.

14. The method of claim 13 , wherein the effective amount is at least 0.2 g/kg of body weight is administered to the mammal.

15. The method of claim 13 , wherein the effective amount is at least 1.0 g per day is administered to the mammal.

16. The method of claim 13 , wherein the mammal is a human.

17. A method of treating diabetes, increasing lipid metabolism, reducing weight, treating dyslipoproteinemia, increasing the amount of Bacteroides fragilis in the gut, decreasing the amount of Enterobacteriaceae bacteria in the gut, increasing the amount of Clostridium bacteria in the gut, or treating lactic acidosis in a mammal in need thereof, the method comprising administering to the mammal in need thereof an effective amount of cold press or hot press dried chardonnay seed flour.

18. The method of claim 17 , wherein the mammal is a human.

19. The method of claim 17 , wherein the effective amount is at least 0.2 g/kg of body weight is administered to the mammal.

20. The method of claim 17 , wherein the effective amount is at least 1.0 g per day is administered to the mammal.

Assignees

• Sonomaceuticals Llc
• Us Agriculture

Inventors

• Arvik Torey James
• Lipson Rebecca Susan
• Yokoyama Wallace H

Classifications

• A61P3/04

  Anorexiants; Antiobesity agents · CPC title

• A61P3/10

  for hyperglycaemia, e.g. antidiabetics · CPC title

• A61K36/87 Primary

  Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine · CPC title